171 related articles for article (PubMed ID: 12065539)
1. Purified malaria pigment (hemozoin) enhances dendritic cell maturation and modulates the isotype of antibodies induced by a DNA vaccine.
Coban C; Ishii KJ; Sullivan DJ; Kumar N
Infect Immun; 2002 Jul; 70(7):3939-43. PubMed ID: 12065539
[TBL] [Abstract][Full Text] [Related]
2. Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies.
Lobo CA; Dhar R; Kumar N
Infect Immun; 1999 Apr; 67(4):1688-93. PubMed ID: 10085005
[TBL] [Abstract][Full Text] [Related]
3. Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infection.
Scheiblhofer S; Chen D; Weiss R; Khan F; Mostböck S; Fegeding K; Leitner WW; Thalhamer J; Lyon JA
Eur J Immunol; 2001 Mar; 31(3):692-8. PubMed ID: 11241272
[TBL] [Abstract][Full Text] [Related]
4. Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons.
Kumar R; Nyakundi R; Kariuki T; Ozwara H; Nyamongo O; Mlambo G; Ellefsen B; Hannaman D; Kumar N
Vaccine; 2013 Jun; 31(31):3140-7. PubMed ID: 23684840
[TBL] [Abstract][Full Text] [Related]
5. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
[TBL] [Abstract][Full Text] [Related]
6. Immune responses induced by gene gun or intramuscular injection of DNA vaccines that express immunogenic regions of the serine repeat antigen from Plasmodium falciparum.
Belperron AA; Feltquate D; Fox BA; Horii T; Bzik DJ
Infect Immun; 1999 Oct; 67(10):5163-9. PubMed ID: 10496891
[TBL] [Abstract][Full Text] [Related]
7. The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol.
Rainczuk A; Smooker PM; Kedzierski L; Black CG; Coppel RL; Spithill TW
Vaccine; 2003 Jun; 21(21-22):3030-42. PubMed ID: 12798647
[TBL] [Abstract][Full Text] [Related]
8. Malaria DNA vaccines in Aotus monkeys.
Gramzinski RA; Maris DC; Doolan D; Charoenvit Y; Obaldia N; Rossan R; Sedegah M; Wang R; Hobart P; Margalith M; Hoffman S
Vaccine; 1997 Jun; 15(8):913-5. PubMed ID: 9234546
[TBL] [Abstract][Full Text] [Related]
9. Differences in epitope recognition, isotype and titer of antisera to Plasmodium falciparum merozoite surface protein 4 raised by different modes of DNA or protein immunization.
Wang L; Menting JG; Black CG; Stowers A; Kaslow DC; Hoffman SL; Coppel RL
Vaccine; 2000 Nov; 19(7-8):816-24. PubMed ID: 11115704
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii.
Kedzierski L; Black CG; Stowers AW; Goschnick MW; Kaslow DC; Coppel RL
Vaccine; 2001 Sep; 19(32):4661-8. PubMed ID: 11535314
[TBL] [Abstract][Full Text] [Related]
11. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.
Sedegah M; Weiss W; Sacci JB; Charoenvit Y; Hedstrom R; Gowda K; Majam VF; Tine J; Kumar S; Hobart P; Hoffman SL
J Immunol; 2000 Jun; 164(11):5905-12. PubMed ID: 10820272
[TBL] [Abstract][Full Text] [Related]
12. Characterization of antibody responses to a Plasmodium falciparum blood-stage antigen induced by a DNA prime/protein boost immunization protocol.
Haddad D; Liljeqvist S; Ståhl S; Hansson M; Perlmann P; Ahlborg N; Berzins K
Scand J Immunol; 1999 May; 49(5):506-14. PubMed ID: 10320644
[TBL] [Abstract][Full Text] [Related]
13. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
Rainczuk A; Scorza T; Spithill TW; Smooker PM
Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
[TBL] [Abstract][Full Text] [Related]
14. Infection with Plasmodium berghei boosts antibody responses primed by a DNA vaccine encoding gametocyte antigen Pbs48/45.
Haddad D; Maciel J; Kumar N
Infect Immun; 2006 Apr; 74(4):2043-51. PubMed ID: 16552033
[TBL] [Abstract][Full Text] [Related]
15. Vaxfectin enhances both antibody and in vitro T cell responses to each component of a 5-gene Plasmodium falciparum plasmid DNA vaccine mixture administered at low doses.
Sedegah M; Rogers WO; Belmonte M; Belmonte A; Banania G; Patterson NB; Rusalov D; Ferrari M; Richie TL; Doolan DL
Vaccine; 2010 Apr; 28(17):3055-65. PubMed ID: 19879998
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
[TBL] [Abstract][Full Text] [Related]
17. Immune responses to liver-stage parasites: implications for vaccine development.
Hollingdale MR; Krzych U
Chem Immunol; 2002; 80():97-124. PubMed ID: 12058653
[No Abstract] [Full Text] [Related]
18. Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen.
Coban C; Ishii KJ; Stowers AW; Keister DB; Klinman DM; Kumar N
Infect Immun; 2004 Jan; 72(1):584-8. PubMed ID: 14688140
[TBL] [Abstract][Full Text] [Related]
19. Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation.
LeBlanc R; Vasquez Y; Hannaman D; Kumar N
Vaccine; 2008 Jan; 26(2):185-92. PubMed ID: 18054817
[TBL] [Abstract][Full Text] [Related]
20. The dendritic cell-specific chemokine, dendritic cell-derived CC chemokine 1, enhances protective cell-mediated immunity to murine malaria.
Bruna-Romero O; Schmieg J; Del Val M; Buschle M; Tsuji M
J Immunol; 2003 Mar; 170(6):3195-203. PubMed ID: 12626578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
